Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinib is used in adults to treat bile duct cancer that has spread to other parts of the body (metastatic) or cannot be removed with surgery. Pemigatinib is usually given afte···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：195
Selpercatinib is a targeted drug for the treatment of RET gene mutations, which was approved by the FDA in May 2020 for the treatment of cancer patients with abnormal RET kinase mu···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：217
Venetoclax reduces the viability of cancer cells by highly selectively inhibiting the function of the Bcl-2 protein. Venetoclax has a low effect on platelets and has been approved ···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：174
Venetoclax is a novel BCL-2 inhibitor that induces apoptosis in cancer cells by binding to the BCL-2 protein. Venetoclax is widely used in the treatment of hematological malignanci···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：204
Venetoclax is the world's only approved selective inhibitor of Bcl-2 that can induce spontaneous apoptosis of cancer cells by specifically binding to Bcl-2 protein and reduce t···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：208
Venetoclax restores normal apoptosis of cancer cells by blocking the anti-apoptotic function of the BCL-2 protein. Indications include chronic lymphocytic leukemia, acute myeloid l···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：214
Venetoclax is the only approved inhibitor of Bcl-2, which achieves high selectivity for Bcl-2 and reduces platelet damage by introducing indole and azaindole groups, making it suit···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：172
Venetoclax is an oral, small-molecule targeted drug that restores the apoptosis ability of cancer cells by blocking the Bcl-2 protein. It is approved for the treatment of CLL, SLL ···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：197
Venetoclax is the world's first approved selective inhibitor of Bcl-2 that induces apoptosis in cancer cells by highly inhibiting Bcl-2 protein. It has a weak affinity for Bcl-···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：232
Pemigatinib is a targeted therapy drug that is of great significance in the treatment of cholangiocarcinoma.Does Pemigatinib have side effects?Any medication can have some side eff···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：182
Pemigatinibis primarily used for the treatment of adult patients with advanced, metastatic or unresectable cholangiocarcinoma who have received at least one prior systemic therapy ···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：178
Pemigatinibhas demonstrated significant efficacy in the treatment of cholangiocarcinoma with FGFR2 fusion or rearrangement features, among other diseases.What are the side effects ···【more】
Article source：Captain MedicineRelease date：2024-08-14Recommended：205
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3172024-09-07
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：102025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：232025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：242025-27-11
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended：3062025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended：2692025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended：3492024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended：2492024-24-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
